Sun Ophthalmic News

Get the latest news from Sun Ophthalmics


Managing Glaucoma from Home

Read more

Managing Dry Eye Disease in Challenging Times

Read more

Sun Pharmaceutical Industries, Inc. Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the U.S. For Potential COVID-19 Treatment

Read more

Sun Ophthalmics to Present Updated CEQUA™ and XELPROS™ Data at AAOPT/WCO 2019

Read more

Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.

Read more

Sun Pharma Introduces Access Program for Patients Prescribed XELPROS in the U.S.

Read more

Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension (1)

Read more

Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease

Read more

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera™ for Treatment of Dry Eye

Read more

Sun Pharma Launches First Branded Ophthalmic Product, BromSite™ in USA

Read more

Sun Pharma to Acquire Ocular Technologies

Read more